Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Surgery. 2013 Aug 6;154(6):1199–1205. doi: 10.1016/j.surg.2013.06.020

Table 2.

Clinicopathologic features of all BRAF V600E mutation positive papillary thyroid cancers with respect to intensity of IHC staining. LVI- lymphovascular invasion, LN metastasis- central nodal disease.

BRAF >2 BRAF ≤2 p value
Total 8 17
Male (%) 1(13) 7(41) 0.205
Age 50 41 0.228
Size (mm) 23 17 0.138
Multifocal (%) 5(63) 10(59) 1
Extrathyroidal extension (%) 7(88) 6(35) 0.03
LVI (%) 8(100) 11(65) 0.129
LN metastasis (%) 6(75) 11(65) 1